XML 25 R19.htm IDEA: XBRL DOCUMENT v3.25.1
Earnings Per Share
6 Months Ended
Mar. 31, 2025
Earnings Per Share [Abstract]  
Earnings Per Share

NOTE M – EARNINGS PER SHARE

The following is the computation of basic and diluted earnings per share ("EPS") from continuing operations attributable to Ashland. Stock appreciation rights and warrants available to purchase shares outstanding for each reporting period whose exercise price was greater than the average market price of Ashland common stock for each applicable period were not included in the computation of income (loss) from continuing operations per diluted share because the effect of these instruments would be antidilutive. The total number of these shares outstanding was approximately 1 million at March 31, 2025 and 2024. The majority of these shares are for warrants with a strike price of $128.66. Earnings per share is reported under the treasury stock method.

 

 

Three months ended

 

 

Six months ended

 

 

 

March 31

 

 

March 31

 

(In millions, except per share data)

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Numerator

 

 

 

 

 

 

 

 

Numerator for basic and diluted EPS - Income (loss) from continuing operations, net of tax

 

$

30

 

 

$

121

 

 

$

(136

)

 

$

149

 

Denominator

 

 

 

 

 

 

 

 

Denominator for basic EPS - Weighted-average common shares outstanding

 

 

47

 

 

 

50

 

 

 

47

 

 

 

50

 

Share based awards convertible to common shares

 

 

 

 

 

1

 

 

 

 

 

 

1

 

Denominator for diluted EPS - Adjusted weighted-average shares and assumed conversions

 

 

47

 

 

 

51

 

 

 

47

 

 

 

51

 

EPS from continuing operations

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.63

 

 

$

2.43

 

 

$

(2.91

)

 

$

2.95

 

Diluted(a)

 

 

0.63

 

 

 

2.40

 

 

 

(2.91

)

 

 

2.92

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(a)
As a result of the loss from continuing operations attributable to Ashland during the six months ended March 31, 2025, the effect of the share-based awards convertible to common stock would be antidilutive and have been excluded from the diluted EPS calculation.